du Cheyron Damien, Chalumeau Cecile, Defontaine Nadia, Klein Christophe, Kellermann Odile, Paillard Michel, Poggioli Josiane
Institut National de la Santé et de la Recherche Médicale, Paris, France.
Kidney Int. 2003 Sep;64(3):939-49. doi: 10.1046/j.1523-1755.2003.00189.x.
Low-concentration angiotensin II (Ang II) stimulates Na+/H+ exchanger 3 (NHE3) activity in renal proximal tubule mainly via angiotensin II type 1 (AT1) receptors. The mechanisms that mediate the increase in NHE3 activity elicited by Ang II remain incompletely settled.
To assess a potential role of NHE3 trafficking in the Ang II effect, NHE3 activity was measured by H+-driven initial rate of 22Na uptake resistant to 50 micromol/L of the Na+/H+ exchange inhibitor cariporide (HOE642), and sensitive to 300 micromol/L ethyl isopropyl amiloride (EIPA), in a model of cultured proximal tubular cells (MKCC), in which functional apical NHE3 and AT receptors are normally present. Apical expression of NHE3 protein was determined by cell surface biotinylation and immunoblotting.
Ang II (10-10 mol/L, 43 minutes) increased NHE3 activity and biotinylated NHE3 protein without any change in total amount of NHE3 protein. Both effects were suppressed by specific AT1 receptor antagonists. When 2-mercaptoethanesulphonic acid (MESNA) was used to cleave biotin from all apical proteins, intracellular biotinylated NHE3 protein remained unchanged after Ang II incubation compared to control. When sulfo-N-hydrosuccinimide (NHS)-acetate was used first to block all apical reactive sites, an increase in biotinylated NHE3 protein was observed following Ang II incubation. To evaluate the role of phosphatidylinositol 3-kinase (PI 3-kinase), the specific inhibitor wortmannin was used. It suppressed Ang II-induced increase in NHE3 activity and trafficking. Furthermore, latrunculin B, inhibitor of actin filament polymerization, prevented both Ang II stimulatory effects.
Ang II stimulates NHE3 activity, at least in part, by exocytic insertion of the protein into the apical membrane. This effect is mediated by PI 3-kinase and required integrity of actin cytoskeleton.
低浓度血管紧张素II(Ang II)主要通过1型血管紧张素II(AT1)受体刺激肾近端小管中的钠氢交换体3(NHE3)活性。介导Ang II引起的NHE3活性增加的机制仍未完全明确。
为评估NHE3转运在Ang II效应中的潜在作用,在培养的近端小管细胞(MKCC)模型中,通过对50微摩尔/升钠氢交换抑制剂卡里波罗(HOE642)耐药且对300微摩尔/升乙基异丙基氨氯吡脒(EIPA)敏感的22Na摄取的H+驱动初始速率来测量NHE3活性,该模型中通常存在功能性顶端NHE3和AT受体。通过细胞表面生物素化和免疫印迹法测定NHE3蛋白的顶端表达。
Ang II(10-10摩尔/升,43分钟)增加了NHE3活性和生物素化的NHE3蛋白,而NHE3蛋白总量无任何变化。这两种效应均被特异性AT1受体拮抗剂抑制。当使用2-巯基乙磺酸钠(MESNA)从所有顶端蛋白上切割生物素时,与对照相比,Ang II孵育后细胞内生物素化的NHE3蛋白保持不变。当首先使用磺基-N-羟基琥珀酰亚胺(NHS)-乙酸酯阻断所有顶端反应位点时,Ang II孵育后观察到生物素化的NHE3蛋白增加。为评估磷脂酰肌醇3激酶(PI 3激酶)的作用,使用了特异性抑制剂渥曼青霉素。它抑制了Ang II诱导的NHE3活性和转运增加。此外,肌动蛋白丝聚合抑制剂拉特鲁毒素B阻止了Ang II的两种刺激效应。
Ang II至少部分地通过将该蛋白胞吐插入顶端膜来刺激NHE3活性。这种效应由PI 3激酶介导,并且需要肌动蛋白细胞骨架的完整性。